TraitHigh for drug- and dose-specific CPIC guidance
Statin muscle-symptom risk (SLCO1B1)
Statin muscle-symptom risk (SLCO1B1) is a genetic trait Biome reports in its medication response panel: An SLCO1B1 result can help a clinician choose a statin and dose. The effect depends on the statin, and the clearest muscle-side-effect link is with simvastatin.
- Category
- Medication response
- Markers
- SLCO1B1 diplotype/phenotype with deletion calling
- Strength of evidence
- High for drug- and dose-specific CPIC guidance
- DNA-test coverage
- Stronger with whole genome
Genes
How Biome reads this
Biome's whole-genome test reads this from one saliva sample, alongside all 3.2 billion letters of your DNA.
Biome DNA test →This page is for educational purposes only and is not medical advice. It is not intended to diagnose, treat, cure, or prevent any disease. Genetic results describe tendencies and predispositions, not diagnoses. Always consult a licensed clinician before making decisions about your health, medications, or supplements.